Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
ZoomInfo Technologies
GTM
$1.24B
| $12.7M | ﹤0.01% |
4,324,554
+3,103,513
| +254% | +$14M |
2020 Q2
24 quarters
|
|
1977
Alpha and Omega Semiconductor
AOSL
$642M
| $12.7M | ﹤0.01% |
267,648
+69,866
| +35% | +$2.81M |
2025 Q2
4 quarters
|
|
1978
Immunovant
IMVT
$6.18B
| $12.7M | ﹤0.01% |
+328,678
| New | +$10M |
2026 Q2
0 quarters
|
|
1979
QuidelOrtho
QDEL
$984M
| $12.7M | ﹤0.01% |
722,480
+440,263
| +156% | +$5.82M |
2025 Q3
3 quarters
|
|
1980
Dave Inc
DAVE
$4.29B
| $12.6M | ﹤0.01% |
33,917
-8,173
| -19% | -$2.12M |
2024 Q1
9 quarters
|
|
1981
Callaway Golf Company
CALY
$2.96B
| $12.6M | ﹤0.01% |
+672,463
| New | +$10.5M |
2026 Q2
0 quarters
|
|
1982
J.M. Smucker
SJM
$14.1B
| $12.6M | ﹤0.01% |
112,258
-179,437
| -62% | -$18.3M |
2018 Q2
32 quarters
|
|
1983
PUT
Diamondback Energy
FANG
$51.2B
| $12.6M | ﹤0.01% |
71,800
+22,500
| +46% | +$4.36M |
2021 Q1
21 quarters
|
|
1984
Under Armour
UAA
$2.48B
| $12.6M | ﹤0.01% |
1,973,897
-1,388,697
| -41% | -$8.23M |
2020 Q1
25 quarters
|
|
1985
FMC
FMC
$999M
| $12.6M | ﹤0.01% |
1,094,883
-20,348
| -2% | -$284K |
2015 Q2
44 quarters
|
|
1986
PUT
Colgate-Palmolive
CL
$78.5B
| $12.6M | ﹤0.01% |
137,300
-15,300
| -10% | -$1.34M |
2019 Q4
26 quarters
|
|
1987
PTC
PTC
$21.2B
| $12.5M | ﹤0.01% |
110,407
+31,197
| +39% | +$4.21M |
2021 Q2
20 quarters
|
|
1988
Codexis
CDXS
$118M
| $12.5M | ﹤0.01% |
5,549,139
+1,551,009
| +39% | +$3.86M |
2025 Q2
4 quarters
|
|
1989
Definium Therapeutics
DFTX
$4.39B
| $12.5M | ﹤0.01% |
266,076
-580,820
| -69% | -$14.4M |
2025 Q2
4 quarters
|
|
1990
MBX Biosciences
MBX
$2.53B
| $12.5M | ﹤0.01% |
226,151
-338,264
| -60% | -$11.8M |
2024 Q3
7 quarters
|
|
1991
CDW
CDW
$21.1B
| $12.5M | ﹤0.01% |
88,615
+55,353
| +166% | +$6.95M |
2024 Q2
8 quarters
|
|
1992
MarketAxess Holdings
MKTX
$5.83B
| $12.4M | ﹤0.01% |
109,590
-977,598
| -90% | -$139M |
2018 Q4
30 quarters
|
|
1993
Evolus
EOLS
$493M
| $12.4M | ﹤0.01% |
1,787,929
+326,770
| +22% | +$1.93M |
2022 Q1
17 quarters
|
|
1994
Petrobras
PBR
$126B
| $12.4M | ﹤0.01% |
767,639
-209,977
| -21% | -$4.1M |
2022 Q2
16 quarters
|
|
1995
PUT
Cintas
CTAS
$90.9B
| $12.4M | ﹤0.01% |
72,900
+59,000
| +424% | +$10.2M |
2023 Q1
13 quarters
|
|
1996
MoonLake Immunotherapeutics
MLTX
$984M
| $12.4M | ﹤0.01% |
636,187
+60,095
| +10% | +$1.09M |
2025 Q3
3 quarters
|
|
1997
Expeditors International
EXPD
$25.7B
| $12.4M | ﹤0.01% |
75,978
-274,665
| -78% | -$42.5M |
2018 Q4
30 quarters
|
|
1998
Metals Acquisition Corp II Units
MTAL.U
| $12.4M | ﹤0.01% |
1,130,000
-800,000
| -41% | -$8.35M |
2026 Q1
1 quarter
|
|
1999
iShares US Medical Devices ETF
IHI
$4.04B
| $12.4M | ﹤0.01% |
+250,020
| New | +$12.7M |
2026 Q2
0 quarters
|
|
2000
Tonix Pharmaceuticals
TNXP
$87.6M
| $12.3M | ﹤0.01% |
966,932
+747,259
| +340% | +$9.6M |
2024 Q3
7 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.